Clinical Evaluation Core

临床评估核心

基本信息

项目摘要

The Clinical Evaluation Core's (CEC) goals are: 1. Recruitment, Characterization and Retention of Human Subjects 2. Uniform Diagnostic Method and Clinical Assessment Battery Across All Projects Including Psychological Autopsies, 3. Methods Development. 4. Maintenance of Reliability among Clinical Staff. 5. Supervise Inpatient Study Phase and Conduct Outpatient Study Phase 6. Consultation to Investigators. The CEC identifies and recruits patients with MDE and post-mortem cases. Normal volunteers are recruited to provide normative values on measures used and to establish psychometric properties of measures in a nonpathological population. The CEC utilizes a core of clinical instruments covering major risk factor domains for suicidal behavior, and ensures uniformity of assessment domains and measures across the projects of the Conte Center. These assessments include Axis I and II diagnostic interviews, measures of state and trait-related risk factors, measures of suicidal behavior, demographic history, life events, social functioning, family psychiatric history. Assessments are performed at intake, at time of biological procedures, at discharge. CEC interacts extensively with other Cores and Projects in the Conte Center. The CEC conducts clinical evaluation, data collection and treatment for all Conte Center projects that include human subjects including the Clinical Project 5, PET Project 3, MRI Project 4 and Statistics Project 6. CEC works closely with the Data Management and Statistics Core (DMSC) staff to generate forms, data management procedures, and reliability statistics. CEC coordinates with the Brain Imaging Core (BIC) regarding subject recruitment, clinical interviewing, matching controls and monitoring drug washouts and subject flow through the brain imaging protocols. The CEC conducts assessments of the suicide victims whose brains are studied by the Postmortem Brain Studies Core (PMC). The CEC obtains blood, hair and saliva from subjects to be analyzed by the Neurobiology Laboratory Core (NLC). The CEC also interfaces with the Administrative Core to identify and recruit new staff and maintain a central database of CEC manuscripts. The CEC coordinates the diagnostic consensus conference for projects # 1 , 2 - 6 and maintains inter-rater reliability. CEC Faculty and staff are an experienced center structure as most have worked as a core for the past 10 years or longer.
临床评估核心(CEC)的目标是:1.招募、表征和保留人类 科目2.所有项目的统一诊断方法和临床评估组合,包括 心理尸检,3.方法发展。4.维护临床工作人员的可靠性。5. 监督住院研究阶段和进行门诊研究阶段6。咨询研究人员。这个 CEC识别和招募MDE患者和尸检病例。招募正常志愿者是为了 为所使用的测量提供标准值,并建立测量的心理测量学属性 非病态人群。CEC使用涵盖主要风险因素的核心临床仪器 自杀行为的领域,并确保整个评估领域和措施的一致性 孔蒂中心的项目。这些评估包括Axis I和II诊断性访谈、测量 与状态和特征相关的危险因素、自杀行为的测量、人口学史、生活事件、社会 功能正常,家族精神病史。评估在进食时进行,在生物时间进行 出院时的程序。CEC与Conte的其他核心和项目广泛互动 中心。CEC为所有CONTE中心项目进行临床评估、数据收集和治疗 包括人类受试者,包括临床项目5、PET项目3、MRI项目4和 统计项目6.CEC与数据管理和统计核心(DMSc)工作人员密切合作 生成表单、数据管理程序和可靠性统计数据。CEC与大脑协调 关于受试者招募、临床访谈、匹配控制和监测的成像核心(BIC) 药物洗脱和受试者通过大脑成像方案流动。CEC对 自杀受害者的大脑由死后脑研究核心(PMC)研究。CEC获得 受试者的血液、头发和唾液将由神经生物学实验室核心(NLC)分析。CEC 还与行政核心对接,以确定和征聘新工作人员,并维护中央数据库 CEC手稿。CEC协调项目#1、2-6和#3的诊断协商一致会议 维护评核人之间的可靠性。与大多数人一样,CEC的教职员工都是经验丰富的中心结构 在过去10年或更长时间内作为核心工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria A Oquendo其他文献

Higher 5-HT1A Receptor Binding Potential During a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study
重大抑郁发作期间较高的 5 -羟色胺 1A 受体结合潜能预示治疗反应不佳:一项自然主义研究的初步数据
  • DOI:
    10.1038/sj.npp.1300992
  • 发表时间:
    2006-01-04
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Ramin V Parsey;Doreen M Olvet;Maria A Oquendo;Yung-yu Huang;R Todd Ogden;J John Mann
  • 通讯作者:
    J John Mann

Maria A Oquendo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria A Oquendo', 18)}}的其他基金

Exploratory-Project 2
探索性项目 2
  • 批准号:
    10675048
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Exploratory-Project 2
探索性项目 2
  • 批准号:
    10672736
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
PRIDE SSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
PRIDE SSA - 在撒哈拉以南非洲实施和传播可持续和可扩展的循证实践的研究伙伴关系
  • 批准号:
    10158539
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
StepWell: Stepped Care Mental Health and Substance Use Telehealth Services for COVID-19 Affected Patients
StepWell:为受 COVID-19 影响的患者提供阶梯式护理心理健康和药物使用远程医疗服务
  • 批准号:
    10198125
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
PRIDE SSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
PRIDE SSA - 在撒哈拉以南非洲实施和传播可持续和可扩展的循证实践的研究伙伴关系
  • 批准号:
    9917820
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
PRIDE SSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence Based Practices in sub-Saharan Africa
PRIDE SSA - 在撒哈拉以南非洲实施和传播可持续和可扩展的循证实践的研究伙伴关系
  • 批准号:
    9317169
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Neurobiological Underpinnings of Two Suicidal Subtypes
两种自杀亚型的神经生物学基础
  • 批准号:
    9055409
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Neurobiological Underpinnings of Two Suicidal Subtypes
两种自杀亚型的神经生物学基础
  • 批准号:
    9272942
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Training in Sex and Gender Differences Research to Improve Women's Health
性别和性别差异研究培训以改善妇女健康
  • 批准号:
    9769090
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
PALOP Mental Health Implementation Research Training
PALOP 心理健康实施研究培训
  • 批准号:
    8853362
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似海外基金

investigation of novel biomarkers for depression by multi-omics analysis of the human biological hippocampus and blood samples
通过对人类生物海马体和血液样本进行多组学分析来研究抑郁症的新型生物标志物
  • 批准号:
    23K14804
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
  • 批准号:
    22K21006
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Establishment of blood-based biomarkers to reflect age-related changes in biological membrane
建立基于血液的生物标志物以反映生物膜与年龄相关的变化
  • 批准号:
    22K19762
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Biological effects of bisphosphonates on bone-specific blood vessels and perivascular cells
双膦酸盐对骨特异性血管和血管周围细胞的生物学效应
  • 批准号:
    22K17000
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
  • 批准号:
    21K18268
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Biological action of PTH/PTHrP on bone-specific blood vessels and osteo-vascular interaction
PTH/PTHrP 对骨特异性血管和骨血管相互作用的生物学作用
  • 批准号:
    21H03103
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular biological analysis on peripheral blood and pharyngeal mucosa of Kawasaki disease children
川崎病患儿外周血及咽黏膜的分子生物学分析
  • 批准号:
    16K10042
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
HHSN2612012000151/HHSN2610006Base Contract Title: Preclinical Efficacy and Intermediate Biomarkers. Task Order Title: Modulation of miRNA Expression in Blood or Other Biological Fluids Compared wi
HHSN2612012000151/HHSN2610006基本合同标题:临床前功效和中间生物标志物。
  • 批准号:
    8947461
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi
现成的全生物小直径血管的开发
  • 批准号:
    8497217
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Establishment of the mesureing system for early diagnosis of Alzheimer's disease using blood biological markers.
建立利用血液生物标志物早期诊断阿尔茨海默病的测量系统。
  • 批准号:
    23790990
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了